Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥22.6bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥47.5bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥23.6bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income¥324m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥598m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income¥331m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥1.4bn2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥615m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥337m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥613m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥233m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥936m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥417m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥22.8bnat 2023-09-30StandaloneAssets
Total assets¥23.6bnat 2023-03-31StandaloneAssets
Total assets¥23.4bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥13.6bnat 2023-09-30StandaloneLiabilities
Total liabilities¥14.3bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥9.3bnat 2023-09-30StandaloneNet assets
Net assets / equity¥9.3bnat 2023-03-31StandaloneNet assets
Net assets / equity¥8.8bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥7.7bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥8.6bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥7.7bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥8.6bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥8.8bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥7.8bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥498m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥1.5bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥134m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥477m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥28m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥311m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥245m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥255m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥22.392023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥9.722023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥90.212022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥40.192022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.72022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥90.042022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥40.122022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥302022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Equity ratio40.5%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio39.4%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.5%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued10,780,000at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued10,780,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued10,780,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥2.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥2.0bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥19.5bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥19.5bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-09-30¥20.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥20.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥1.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥1.7bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥20.3bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥20.3bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-09-30¥21.9bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥21.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 455
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1693719000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember23618244000JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember-JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember20292327000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1632197000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember21924524000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1693719000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember23618244000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember2241385000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember188648000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember2430034000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember200721000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember2630755000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember19484583000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1157372000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember20641956000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1990893000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember22632850000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember-JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember19484583000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1157372000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember20641956000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1990893000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember22632850000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember1954922000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember148742000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember2103664000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember228787000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember2332451000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第38期第2四半期(自 2023年7月1日 至 2023年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)ディーブイエックス株式会社
Company name in english cover pageFilingDateInstantDVx Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長  柴﨑 浩
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都豊島区高田二丁目17-22
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-5985-6123(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役執行役員  宮本 聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都豊島区高田二丁目17-22
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5985-6123(代表)

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass